Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Dow
Medtronic
Express Scripts
AstraZeneca
Colorcon

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Pfizer Inc Company Profile

See Plans and Pricing

« Back to Dashboard

US Patents for Pfizer Inc

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Pfizer Inc IXIFI infliximab-qbtx INJECTABLE;INJECTION 761072 001 2017-12-13 RX
Pfizer Inc TRAZIMERA trastuzumab-qyyp INJECTABLE;INJECTION 761081 001 2019-03-11 RX
Pfizer Inc ZIRABEV bevacizumab-bvzr INJECTABLE;INJECTION 761099 001 2019-06-27 RX
Pfizer Inc ZIRABEV bevacizumab-bvzr INJECTABLE;INJECTION 761099 002 2019-06-27 RX
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
McKesson
Medtronic
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.